20 May 2013
Keywords: abgenix, losses, widen, second, quarter, biotechnology, firm
Article | 27 July 2001
US biotechnology firm Abgenix reported a net loss of $14.8 million, or$0.17 per share, for the second quarter of 2001, compared with ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.